Despite increasing awareness, identifying and mitigating the effects of ACEs remains a significant challenge, particularly ...

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

New research on ‘slow-wave sleep’ may have implications for others battling insomnia, including people with anxiety and ...

Difficulty focusing, hyperactivity, and impulsive behaviour are key signs of ADHD. If your child has this neurodevelopmental ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.

Strattera is prescribed to treat ADHD. Learn more about how long the drug takes to kick in and how long it lasts.

Although stimulant dispensing rates have rebounded to — or exceeded — pre-pandemic levels among girls, the dispensing rate ...

Imagine constantly battling with your thoughts, being unable to focus, or needing to move when the world expects you to stay ...

Attention-deficit hyperactivity disorder (ADHD) is a well-known neurodevelopmental disorder that affects the brain's ability to regulate attention and control impulses.

Many cycles of depressive episodes can be prevented via the diagnosis and treatment of underlying ADHD. Learn about the link between ADHD and recurrent depression.

Like so many problems facing health service delivery in New Zealand, the primary driver for the proposed changes is inadequate resourcing, writes Associate Professor Ben Beaglehole ...